The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
post
The Road to Regulatory Modernization: FDA Modernization Act 3.0, NAMs, and the Future of Nonclinical Testing
Read More
infographic
Navigating the Regulatory Crossroads of Drug, Device, and Biologic
Read More
post
FDA PreCheck Program vs. Fast Track: Facility Readiness
Read More
post
QSR Is Gone. What Combination Product Sponsors Need to Know About the QMSR Switchover.
Read More
Let's move from science to success.
Let’s Talk